Global News
globalnews.ca › news › 10476494 › wegovy-drug-canada-weight-loss-drug
Wegovy now in Canada: Who should (and shouldn’t) use the weight-loss drug - National | Globalnews.ca
May 7, 2024 - After years of persistent shortages, Canadians can now access Wegovy, an on-label weight loss medication, made by the same manufacturers of Ozempic. Novo Nordisk’s drug officially hit the shelves on Monday, marking its availability despite ...
Drug and Health Products Portal
dhpp.hpfb-dgpsa.ca › review-documents › resource › RDS00896
Regulatory Decision Summary for Wegovy - Drug and Health Products Portal
The Regulatory Decision Summary explains Health Canada’s decision for the product seeking market authorization. The Regulatory Decision Summary includes the purpose of the submission and the reason for the decision. ... The purpose of this submission was to seek authorization for Wegovy (semaglutide injection).
Wegovy
wegovy.ca
Wegovy® | For Canadian Patients and HCPs
Wegovy® (semaglutide injection) resources for Canadians. Wegovy®, semaglutide, semaglutide injection, Novo Nordisk, Novo Nordisk Canada, NNCI, Novo Nordisk Care.
Novo Nordisk Canada
novonordisk.ca › content › dam › nncorp › ca › en › press-releases › 2024 › wegovy-commercial-availability-press-release-en-may-2-24.pdf pdf
wegovy-commercial-availability-press-release-en-may-2- ...
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases.
Health Products
health-products.canada.ca › dpd-bdpp › info
Health Canada - Product Information
SINGLE DOSE PREFILLED PEN Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.
Novo Nordisk Canada
novonordisk.ca › content › dam › nncorp › ca › en › products › Wegovy-consumer-information.pdf pdf
Wegovy-consumer-information.pdf
may be you or a person you are caring for. Read this information carefully. Keep it as you may ... This patient medication information is a summary. It will not tell you everything about this · medication. If you have more questions about this medication or want more information about · WEGOVY®, talk to a healthcare professional. ... WEGOVY® is supplied as a clear and colourless solution for injection in a pre-filled pen. WEGOVY® is available in a carton of 4 single-use, disposable, pre-filled pens delivering doses
Novo Nordisk Canada
novonordisk.ca › content › dam › nncorp › ca › en › press-releases › 2024 › wegovy-non-fatal-mi-indication-announcement-press-release-112624.pdf pdf
wegovy-non-fatal-mi-indication-announcement-press- ...
Novo Nordisk Canada Inc. ... Treatment Effect in People with Obesity) clinical trial program. In the largest phase 3a trial, STEP 1, results showed that patients taking Wegovy® achieved a mean weight loss of 15 per · cent (15 kg) sustained over 68 weeks. In addition, 83.5 per cent of patients achieved 5 per · cent or more body weight reduction in the Wegovy® arm vs. 31.1 per cent for placebo. Wegovy® is available ...